Pharmacolog takes further orders in Germany
The private pharmacy Obertor Apotheke in Esslingen, Germany, has ordered a DrugLog® system. The system shall be used for the final control of ophthalmic drugs. The transaction was carried out by Pharmacolog's distributor in Germany, AddedPharma GmbH.
Obertor Apotheke in Esslingen, Germany, southeast of Stuttgart, is a private pharmacy that, in addition to providing medicines to the public, also prepares and prepares a variety of medicines and substances for private practitioners and health centers. Germany has over 17,000 private pharmacies, so-called Community Pharmacies, compared with a total of 2,200 hospital pharmacies. Obertor Apotheke will initially use DrugLog for quality assurance of special ophthalmic drugs but intends to also include cytotoxic preparations at a later stage. The transaction was completed via Pharmacolog's German distributor AddedPharma GmbH and involves an order value for Pharmacolog of approximately SEK 300,000.
Mats Högberg, CEO of Pharmacolog: “The private pharmacy sector in Germany with over 17,000 pharmacies is a very interesting business segment for Pharmacolog. It is therefore very gratifying that our partner, AddedPharma, has succeeded in breaking into this market, despite an ongoing pandemic that significantly complicates sales work. The installation at Obertor Apotheke will also be an important reference installation for Pharmacolog in Germany. As the German authorities increase the requirements for quality assurance of drug preparations, we see an increased demand for art-efficient systems for preparation control.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on March 19, 2021 at 16:40.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company's first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog's long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at www.pharmacolog.com. The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
